Procedimentos ablativos na doença de Parkinson: uma ferramenta esquecida?
DOI:
https://doi.org/10.34024/rnc.2019.v27.10178Palavras-chave:
Procedimentos ablativos, Parkinson, opiniãoResumo
opinião
Downloads
Não há dados estatísticos.
Métricas
Carregando Métricas ...
Referências
1.Muangpaisan W, Mathews A, Hori H, Seidel D. A systematic review of the worldwide prevalence and incidence of Parkinson’s disease. J Med Assoc Thai 2011;94:749.
http://webcache.googleusercontent.com/search?q=cache:https://pdfs.semanticscholar.org/0a8a/0e1ffd8bdff164eb548f4c5ca578aaacf542.pdf
2.Muangpaisan W, Hori H, Brayne C. Systematic review of the prevalence and incidence of Parkinson's disease in Asia. J Epidemiol 2009;19:281-93. https://doi.org/10.2188/jea.je20081034
3.Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003;157:1015-22. https://doi.org/10.1093/aje/kwg068
4.Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-12. https://doi.org/10.1136/jnnp.69.3.308
5.Castrioto A, Lozano AM, Poon Y-Y, Lang AE, Fallis M, Moro E. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol 2011;68:1550-6. https://doi.org/10.1001/archneurol.2011.182
6.Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K, et al. A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease. New Engl J Med 2006;355:896-908. https://doi.org/10.1056/NEJMoa060281
7.Gervais-Bernard H, Xie-Brustolin J, Mertens P, Polo G, Klinger H, Adamec D, et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson’s disease: five year follow-up. J Neurol 2009;256:225-33. https://doi.org/10.1007/s00415-009-0076-2
8.Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301:63-73. https://doi.org/10.1001/jama.2008.929
9.Nagatsu T, Sawada M. L-dopa therapy for Parkinson's disease: past, present, and future. Parkinsonism Relat Disord 2009;15:S3-8. https://doi.org/10.1016/S1353-8020(09)70004-5
10.Liss B, Striessnig J. The potential of l-type calcium channels as a drug target for neuroprotective therapy in Parkinson's disease. Annu Rev Pharmacol Toxicol 2019;59:263-89. https://doi.org/10.1146/annurev-pharmtox-010818-021214
11.Jain KK. Neuroprotection in Parkinson Disease. In: The Handbook of Neuroprotection. Springer; 2019, p.403-63.
12.Spindola B, Leite MA, Orsini M, Fonoff E, Landeiro JA, Pessoa BL. Ablative surgery for Parkinson's disease: Is there still a role for pallidotomy in the deep brain stimulation era? Clin Neurol Neurosurg 2017;158:33-9. https://doi.org/10.1016/j.clineuro.2017.04.018
13.de Bie R, de Haan RJ, Nijssen PC, Rutgers AWF, Beute GN, Bosch DA, et al. Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial. Lancet 1999;354:1665-9.
https://doi.org/10.1016/S0140-6736(99)03556-4
14.Lozano AM, Gildenberg PL, Tasker RR. In: Textbook of stereotactic and functional neurosurgery. Springer; 2009.
15.Fine J, Duff J, Chen R, Hutchison W, Lozano AM, Lang AE. Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. N Engl J Med 2000;342:1708-14. https://doi.org/10.1056/NEJM200006083422304
16.De Bie R, De Haan R, Schuurman P, Esselink R, Bosch D, Speelman J. Morbidity and mortality following pallidotomy in Parkinson’s disease A systematic review. Neurology 2002;58:1008-12. https://doi.org/10.1212/wnl.58.7.1008
17.Esselink R, De Bie R, De Haan R, Lenders M, Nijssen P, Staal M, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD A randomized trial. Neurology 2004;62:201-7. https://doi.org/10.1212/01.wnl.0000103235.12621.c3
18.Vitek JL, Bakay RA, Freeman A, Evatt M, Green J, McDonald W, et al. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease. Ann Neurol 2003;53:558-69. https://doi.org/10.1002/ana.10517
http://webcache.googleusercontent.com/search?q=cache:https://pdfs.semanticscholar.org/0a8a/0e1ffd8bdff164eb548f4c5ca578aaacf542.pdf
2.Muangpaisan W, Hori H, Brayne C. Systematic review of the prevalence and incidence of Parkinson's disease in Asia. J Epidemiol 2009;19:281-93. https://doi.org/10.2188/jea.je20081034
3.Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of Parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003;157:1015-22. https://doi.org/10.1093/aje/kwg068
4.Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-12. https://doi.org/10.1136/jnnp.69.3.308
5.Castrioto A, Lozano AM, Poon Y-Y, Lang AE, Fallis M, Moro E. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch Neurol 2011;68:1550-6. https://doi.org/10.1001/archneurol.2011.182
6.Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K, et al. A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease. New Engl J Med 2006;355:896-908. https://doi.org/10.1056/NEJMoa060281
7.Gervais-Bernard H, Xie-Brustolin J, Mertens P, Polo G, Klinger H, Adamec D, et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson’s disease: five year follow-up. J Neurol 2009;256:225-33. https://doi.org/10.1007/s00415-009-0076-2
8.Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301:63-73. https://doi.org/10.1001/jama.2008.929
9.Nagatsu T, Sawada M. L-dopa therapy for Parkinson's disease: past, present, and future. Parkinsonism Relat Disord 2009;15:S3-8. https://doi.org/10.1016/S1353-8020(09)70004-5
10.Liss B, Striessnig J. The potential of l-type calcium channels as a drug target for neuroprotective therapy in Parkinson's disease. Annu Rev Pharmacol Toxicol 2019;59:263-89. https://doi.org/10.1146/annurev-pharmtox-010818-021214
11.Jain KK. Neuroprotection in Parkinson Disease. In: The Handbook of Neuroprotection. Springer; 2019, p.403-63.
12.Spindola B, Leite MA, Orsini M, Fonoff E, Landeiro JA, Pessoa BL. Ablative surgery for Parkinson's disease: Is there still a role for pallidotomy in the deep brain stimulation era? Clin Neurol Neurosurg 2017;158:33-9. https://doi.org/10.1016/j.clineuro.2017.04.018
13.de Bie R, de Haan RJ, Nijssen PC, Rutgers AWF, Beute GN, Bosch DA, et al. Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial. Lancet 1999;354:1665-9.
https://doi.org/10.1016/S0140-6736(99)03556-4
14.Lozano AM, Gildenberg PL, Tasker RR. In: Textbook of stereotactic and functional neurosurgery. Springer; 2009.
15.Fine J, Duff J, Chen R, Hutchison W, Lozano AM, Lang AE. Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. N Engl J Med 2000;342:1708-14. https://doi.org/10.1056/NEJM200006083422304
16.De Bie R, De Haan R, Schuurman P, Esselink R, Bosch D, Speelman J. Morbidity and mortality following pallidotomy in Parkinson’s disease A systematic review. Neurology 2002;58:1008-12. https://doi.org/10.1212/wnl.58.7.1008
17.Esselink R, De Bie R, De Haan R, Lenders M, Nijssen P, Staal M, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD A randomized trial. Neurology 2004;62:201-7. https://doi.org/10.1212/01.wnl.0000103235.12621.c3
18.Vitek JL, Bakay RA, Freeman A, Evatt M, Green J, McDonald W, et al. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease. Ann Neurol 2003;53:558-69. https://doi.org/10.1002/ana.10517
Downloads
Publicado
2019-12-29
Como Citar
Pessoa, B. L., Leite, M. A. A., Orsini, M., Moreno, A. M., & Azizi, M. A. A. (2019). Procedimentos ablativos na doença de Parkinson: uma ferramenta esquecida?. Revista Neurociências, 27, 1–6. https://doi.org/10.34024/rnc.2019.v27.10178
Edição
Seção
Texto de Opinião
Recebido: 2019-12-29
Publicado: 2019-12-29
Publicado: 2019-12-29
Português
English
Español
